Total planned funding: $40,653,449
Allocations
Countries/Regions
| Central Asia Region | $40,653,449 |
Organizational Types
| Own Agency | $11,862,362 |
| Unknown | $8,408,510 |
| NGO | $6,103,170 |
| University | $5,142,658 |
| Host Country Government Agency | $4,917,620 |
| Private Contractor | $3,632,129 |
| Multi-lateral Agency | $420,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $0 |
Program Areas
| Prevention | $15,156,115 |
| Management and Operations | $8,768,822 |
| Governance and Systems | $6,152,648 |
| Care | $4,794,049 |
| Treatment | $3,041,360 |
| Testing | $2,740,455 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,272,423 |
| HVMS: Management and Operations | $8,768,822 |
| HBHC: Care: Adult Care and Support | $3,871,434 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,639,205 |
| HTXS: Treatment: Adult Treatment | $3,008,191 |
| HLAB: Laboratory Infrastructure | $2,803,620 |
| HVCT: Testing: HIV Testing and Counseling | $2,740,455 |
| HVSI: Strategic Information | $2,028,631 |
| OHSS: Health Systems Strengthening | $1,320,397 |
| HVTB: Care: TB/HIV | $922,615 |
| HMBL: Biomedical Prevention: Blood Safety | $916,738 |
| HMIN: Biomedical Prevention: Injection Safety | $327,749 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
USG Aggregated Agencies:
$6,499,999
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2017 | $1,400,000 |
Population Services International:
$5,312,378
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2014 | $0 |
| 2017 | $2,001,384 |
Columbia University:
$5,142,658
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2014 | $1,051,915 |
| 2017 | $3,163,000 |